 | • レポートコード：MRC23Q36312 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、85ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の放射線肺炎治療市場について調査・分析し、世界の放射線肺炎治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（血液検査、肺機能検査、レントゲン検査、CTスキャン）、用途別セグメント分析（病院、外科センター、クリニック、リハビリテーションセンター）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Provision Healthcare、Hitachi、Elekta AB (pub)、C. R. Bard、Optivus Proton Therapy、Mevion Medical Systems、Panacea Medical Technologies、Isoray Medical、Varian Medical Systemsなどが含まれています。 世界の放射線肺炎治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、放射線肺炎治療市場規模を推定する際に考慮しました。本レポートは、放射線肺炎治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、放射線肺炎治療に関するビジネス上の意思決定に役立てることを目的としています。 ・放射線肺炎治療市場の概要 - 放射線肺炎治療のタイプ別セグメント - 世界の放射線肺炎治療市場規模：タイプ別分析（血液検査、肺機能検査、レントゲン検査、CTスキャン） - 放射線肺炎治療の用途別セグメント - 世界の放射線肺炎治療市場規模：用途別分析（病院、外科センター、クリニック、リハビリテーションセンター） - 世界の放射線肺炎治療市場規模予測（2018年-2029年） ・放射線肺炎治療市場の成長トレンド - 放射線肺炎治療の地域別市場規模（2018年-2029年） - 放射線肺炎治療市場ダイナミクス - 放射線肺炎治療の業界動向 - 放射線肺炎治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：血液検査、肺機能検査、レントゲン検査、CTスキャン - 世界の放射線肺炎治療のタイプ別市場規模（2018年-2023年） - 世界の放射線肺炎治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、外科センター、クリニック、リハビリテーションセンター - 世界の放射線肺炎治療の用途別市場規模（2018年-2023年） - 世界の放射線肺炎治療の用途別市場規模（2024年-2029年） ・放射線肺炎治療の地域別市場規模 - 北米の放射線肺炎治療市場規模（2018年-2029年） - アメリカの放射線肺炎治療市場規模（2018年-2029年） - ヨーロッパの放射線肺炎治療市場規模（2018年-2029年） - アジア太平洋の放射線肺炎治療市場規模（2018年-2029年） - 中国の放射線肺炎治療市場規模（2018年-2029年） - 日本の放射線肺炎治療市場規模（2018年-2029年） - 韓国の放射線肺炎治療市場規模（2018年-2029年） - インドの放射線肺炎治療市場規模（2018年-2029年） - オーストラリアの放射線肺炎治療市場規模（2018年-2029年） - 中南米の放射線肺炎治療市場規模（2018年-2029年） - 中東・アフリカの放射線肺炎治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Provision Healthcare、Hitachi、Elekta AB (pub)、C. R. Bard、Optivus Proton Therapy、Mevion Medical Systems、Panacea Medical Technologies、Isoray Medical、Varian Medical Systems ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Radiation Pneumonitis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Radiation Pneumonitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Radiation Pneumonitis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Radiation Pneumonitis Treatment in Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Radiation Pneumonitis Treatment include Provision Healthcare, Hitachi, Elekta AB (pub), C. R. Bard, Optivus Proton Therapy, Mevion Medical Systems, Panacea Medical Technologies, Isoray Medical and Varian Medical Systems, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Radiation Pneumonitis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiation Pneumonitis Treatment.
The Radiation Pneumonitis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Radiation Pneumonitis Treatment market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Radiation Pneumonitis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Provision Healthcare
Hitachi
Elekta AB (pub)
C. R. Bard
Optivus Proton Therapy
Mevion Medical Systems
Panacea Medical Technologies
Isoray Medical
Varian Medical Systems
Segment by Type
Blood Test
Pulmonary Function Test
X-Ray Check
Computed Tomography (Ct) Scan
Segment by Application
Hospitals
Surgical Centers
Clinics
Rehabilitation Centers
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Radiation Pneumonitis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Pneumonitis Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Blood Test
1.2.3 Pulmonary Function Test
1.2.4 X-Ray Check
1.2.5 Computed Tomography (Ct) Scan
1.3 Market by Application
1.3.1 Global Radiation Pneumonitis Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Clinics
1.3.5 Rehabilitation Centers
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiation Pneumonitis Treatment Market Perspective (2018-2029)
2.2 Radiation Pneumonitis Treatment Growth Trends by Region
2.2.1 Global Radiation Pneumonitis Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiation Pneumonitis Treatment Historic Market Size by Region (2018-2023)
2.2.3 Radiation Pneumonitis Treatment Forecasted Market Size by Region (2024-2029)
2.3 Radiation Pneumonitis Treatment Market Dynamics
2.3.1 Radiation Pneumonitis Treatment Industry Trends
2.3.2 Radiation Pneumonitis Treatment Market Drivers
2.3.3 Radiation Pneumonitis Treatment Market Challenges
2.3.4 Radiation Pneumonitis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Radiation Pneumonitis Treatment Players by Revenue
3.1.1 Global Top Radiation Pneumonitis Treatment Players by Revenue (2018-2023)
3.1.2 Global Radiation Pneumonitis Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Radiation Pneumonitis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Radiation Pneumonitis Treatment Revenue
3.4 Global Radiation Pneumonitis Treatment Market Concentration Ratio
3.4.1 Global Radiation Pneumonitis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Pneumonitis Treatment Revenue in 2022
3.5 Radiation Pneumonitis Treatment Key Players Head office and Area Served
3.6 Key Players Radiation Pneumonitis Treatment Product Solution and Service
3.7 Date of Enter into Radiation Pneumonitis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Pneumonitis Treatment Breakdown Data by Type
4.1 Global Radiation Pneumonitis Treatment Historic Market Size by Type (2018-2023)
4.2 Global Radiation Pneumonitis Treatment Forecasted Market Size by Type (2024-2029)
5 Radiation Pneumonitis Treatment Breakdown Data by Application
5.1 Global Radiation Pneumonitis Treatment Historic Market Size by Application (2018-2023)
5.2 Global Radiation Pneumonitis Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiation Pneumonitis Treatment Market Size (2018-2029)
6.2 North America Radiation Pneumonitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Radiation Pneumonitis Treatment Market Size by Country (2018-2023)
6.4 North America Radiation Pneumonitis Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Radiation Pneumonitis Treatment Market Size (2018-2029)
7.2 Europe Radiation Pneumonitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Radiation Pneumonitis Treatment Market Size by Country (2018-2023)
7.4 Europe Radiation Pneumonitis Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Radiation Pneumonitis Treatment Market Size (2018-2029)
8.2 Asia-Pacific Radiation Pneumonitis Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Radiation Pneumonitis Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Radiation Pneumonitis Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Radiation Pneumonitis Treatment Market Size (2018-2029)
9.2 Latin America Radiation Pneumonitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Radiation Pneumonitis Treatment Market Size by Country (2018-2023)
9.4 Latin America Radiation Pneumonitis Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Radiation Pneumonitis Treatment Market Size (2018-2029)
10.2 Middle East & Africa Radiation Pneumonitis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Radiation Pneumonitis Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Radiation Pneumonitis Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Provision Healthcare
11.1.1 Provision Healthcare Company Detail
11.1.2 Provision Healthcare Business Overview
11.1.3 Provision Healthcare Radiation Pneumonitis Treatment Introduction
11.1.4 Provision Healthcare Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.1.5 Provision Healthcare Recent Development
11.2 Hitachi
11.2.1 Hitachi Company Detail
11.2.2 Hitachi Business Overview
11.2.3 Hitachi Radiation Pneumonitis Treatment Introduction
11.2.4 Hitachi Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.2.5 Hitachi Recent Development
11.3 Elekta AB (pub)
11.3.1 Elekta AB (pub) Company Detail
11.3.2 Elekta AB (pub) Business Overview
11.3.3 Elekta AB (pub) Radiation Pneumonitis Treatment Introduction
11.3.4 Elekta AB (pub) Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.3.5 Elekta AB (pub) Recent Development
11.4 C. R. Bard
11.4.1 C. R. Bard Company Detail
11.4.2 C. R. Bard Business Overview
11.4.3 C. R. Bard Radiation Pneumonitis Treatment Introduction
11.4.4 C. R. Bard Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.4.5 C. R. Bard Recent Development
11.5 Optivus Proton Therapy
11.5.1 Optivus Proton Therapy Company Detail
11.5.2 Optivus Proton Therapy Business Overview
11.5.3 Optivus Proton Therapy Radiation Pneumonitis Treatment Introduction
11.5.4 Optivus Proton Therapy Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.5.5 Optivus Proton Therapy Recent Development
11.6 Mevion Medical Systems
11.6.1 Mevion Medical Systems Company Detail
11.6.2 Mevion Medical Systems Business Overview
11.6.3 Mevion Medical Systems Radiation Pneumonitis Treatment Introduction
11.6.4 Mevion Medical Systems Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.6.5 Mevion Medical Systems Recent Development
11.7 Panacea Medical Technologies
11.7.1 Panacea Medical Technologies Company Detail
11.7.2 Panacea Medical Technologies Business Overview
11.7.3 Panacea Medical Technologies Radiation Pneumonitis Treatment Introduction
11.7.4 Panacea Medical Technologies Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.7.5 Panacea Medical Technologies Recent Development
11.8 Isoray Medical
11.8.1 Isoray Medical Company Detail
11.8.2 Isoray Medical Business Overview
11.8.3 Isoray Medical Radiation Pneumonitis Treatment Introduction
11.8.4 Isoray Medical Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.8.5 Isoray Medical Recent Development
11.9 Varian Medical Systems
11.9.1 Varian Medical Systems Company Detail
11.9.2 Varian Medical Systems Business Overview
11.9.3 Varian Medical Systems Radiation Pneumonitis Treatment Introduction
11.9.4 Varian Medical Systems Revenue in Radiation Pneumonitis Treatment Business (2018-2023)
11.9.5 Varian Medical Systems Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details